Qing Qiao

ORCID: 0000-0002-2549-6415
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiovascular Function and Risk Factors
  • Cardiovascular Health and Risk Factors
  • Cardiac pacing and defibrillation studies
  • Heart Failure Treatment and Management
  • Diabetes Treatment and Management
  • Blood Pressure and Hypertension Studies
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Cardiac electrophysiology and arrhythmias
  • Cardiac Arrhythmias and Treatments
  • Atrial Fibrillation Management and Outcomes
  • Sirtuins and Resveratrol in Medicine
  • Gastric Cancer Management and Outcomes
  • Autophagy in Disease and Therapy
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Esophageal Cancer Research and Treatment
  • Acute Myocardial Infarction Research
  • Metastasis and carcinoma case studies
  • Cardiovascular Health and Disease Prevention
  • Esophageal and GI Pathology
  • Endoplasmic Reticulum Stress and Disease
  • Cardiac, Anesthesia and Surgical Outcomes
  • Coronary Artery Anomalies
  • Health Systems, Economic Evaluations, Quality of Life
  • Protease and Inhibitor Mechanisms
  • Anesthesia and Pain Management

Soochow University
2012-2025

Air Force Medical University
2009-2024

Third Affiliated Hospital of Zhengzhou University
2024

Boehringer Ingelheim (Germany)
2021-2024

Fourth People’s Hospital of Jinan
2024

Shandong First Medical University
2024

Kaiser Permanente Center for Health Research
2022-2024

Boehringer Ingelheim (Egypt)
2023

Capital Medical University
2021

National Clinical Research
2021

The effects of systolic blood pressure (SBP), serum total cholesterol (TC), fasting plasma glucose (FPG), and body mass index (BMI) on the risk cardiovascular diseases (CVD) have been established in epidemiological studies, but consistent estimates effect sizes by age sex are not available.We reviewed large cohort pooling projects, evaluating baseline or usual exposure to metabolic risks ischemic heart disease (IHD), hypertensive (HHD), stroke, diabetes, and, as relevant selected other CVDs,...

10.1371/journal.pone.0065174 article EN cc-by PLoS ONE 2013-07-30

This study aims to analyze the adverse drug events (ADEs) associated with tolvaptan in Food and Drug Administration Adverse Event Reporting System database from fourth quarter of 2009 second 2024. After standardizing data, various signal detection techniques, including Odds Ratio (ROR), Proportional (PRR), Bayesian Confidence Propagation Neural Network, Multi-Item Gamma Poisson Shrinker, were employed for analysis. Among 7,486 ADE reports where was primary suspected drug, a total 196...

10.3389/fphar.2024.1509310 article EN cc-by Frontiers in Pharmacology 2025-01-09

Abstract Aims Contemporary estimates of heart failure (HF) prevalence in Japan are scarce. We aimed to estimate HF and trends using nationally representative, large administrative claims databases. Methods results This retrospective analysis used data from the Medical Data Center (JMDC) (age ≤74 years) Vision (MDV) (all ages) databases (study period: 1 January 2014–31 December 31 2019). calculated crude sex‐/age‐standardized models (weighting based on Japanese census data, 2014–2019). Among...

10.1002/ehf2.14321 article EN cc-by-nc ESC Heart Failure 2023-04-05

Abstract Background To investigate the efficacy of different doses corticosteroids in treating severe coronavirus disease 2019 (COVID-19) pneumonia. Methods Between May 01, 2023, and June 20, 48 patients with COVID-19 pneumonia were treated at Department Respiratory Critical Care Medicine Jinan Fourth People's Hospital. The observation group (21 patients) received standard care high-dose corticosteroids, (high-dose group). control (27 low-dose (low-dose We collected baseline data recorded...

10.1186/s12985-024-02345-7 article EN cc-by Virology Journal 2024-03-26

Performances of the Acute Physiology and Chronic Health Evaluation II (APACHE II) score Sequential Organ Failure Assessment (SOFA) were assessed in predicting mortality outcome critically ill elderly patients.Mean APACHE SOFA scores compared 106 intensive care unit patients aged > 65 years classified as survivors or deaths. The discriminatory ability was evaluated using area under receiver operating characteristic (ROC) curve. Calibration Hosmer-Lemeshow test.Mean lower than those who died....

10.1177/147323001204000331 article EN cc-by-nc Journal of International Medical Research 2012-06-01

Hypoxic microenvironments play a significant role in the progression of colorectal cancer (CRC). Silencing information regulator 1 (SIRT1), class III histone deacetylase, modulates multiple biological behaviors cancer. However, its CRC remains unclear. This study aims to explore SIRT1 migration and invasion under hypoxia.SIRT1 protein mRNA levels were detected by Western blotting real-time PCR cells exposed hypoxia (1% O2). The abilities SW480 HCT116 with overexpression or knockdown studied...

10.1186/s12935-019-0819-9 article EN cc-by Cancer Cell International 2019-04-30

Circadian negative feedback loop (CNFL) genes play important roles in cancer development and progression. To evaluate the effects of single nucleotide polymorphisms (SNPs) CNFL on survival GC patients, 13 functional SNPs from 5 were genotyped a cohort 1030 resected patients (704 training set, 326 validation set) to explore association with overall (OS). Among SNPs, three (rs1056560 CRY1, rs3027178 PER1 rs228729 PER3) significantly associated OS verified set pooled analysis. Furthermore,...

10.1038/srep22424 article EN cc-by Scientific Reports 2016-03-01

Sirtuin1 (SIRT1) is a mammalian NAD+-dependent type III deacetylase that plays paramount roles in diverse cellular processes. The nucleocytoplasmic shuttling of SIRT1 was discovered more than decade ago, but the subcellular localization tumor progression remain unclear. Here, we report cytoplasmic acts as suppressor ovarian carcinoma. By creating carcinoma cell lines overexpressing wild-type and nuclear signals (NLSs) mutated together with both unbiased proteomic acetylomic approaches...

10.1007/s11010-019-03559-y article EN cc-by Molecular and Cellular Biochemistry 2019-07-17

Background Stenting of airway stenosis is a common procedure in specialized centers. The aim this study was to summarize our clinical experience ventilation strategy and anesthesia management patients undergoing urgent tracheal stenting. Methods Clinical data 22 with severe who underwent endoscopic placement stent during 2‐year period were retrospectively reviewed. efficacy safety different strategies veno‐arterial extracorporeal membrane oxygenation ( ECMO ), individualized based on the...

10.1111/aas.13062 article EN Acta Anaesthesiologica Scandinavica 2018-01-07

Abstract Therapeutic resistance is a notable cause of death in patients with ovarian carcinoma. Polyploid giant cancer cells (PGCCs), commonly arising tumor tissues following chemotherapy, have recently been considered to contribute drug resistance. As type III deacetylase, Sirtuin1 (SIRT1) plays essential roles the cell cycle, cellular senescence, and Accumulating evidence has suggested that alteration its subcellular localization via nucleocytoplasmic shuttling critical process influencing...

10.1002/path.6167 article EN The Journal of Pathology 2023-08-11

Background: Aspergillus has become the second most common causative agent of invasive fungal infections and is leading cause death from infections. Methods: English‐language publications ranging 1975 to 2022 collected Web Science Core Collection database were analyzed visually using VOSviewer, R package Bibliometrix, Scimago graphic, Gephi, Pajek, Microsoft Excel 365. Literature search advanced function in WoSCC with formula “TS=(Aspergillus).” The inclusion criteria as follows: (1) article...

10.1155/carj/6199860 article EN cc-by Canadian Respiratory Journal 2024-01-01

Abstract Immune checkpoint inhibitors combined with chemotherapy have shown promising efficacy in treating gastric or gastroesophageal junction (G/GEJ) adenocarcinoma the neoadjuvant setting. This phase II trial (NCT05715632) aimed to investigate and safety of perioperative camrelizumab plus XELOX patients locally advanced G/GEJ adenocarcinoma. Treatment‐naive cT3‐4aN1‐3 M0 resectable were recruited receive (200 mg, intravenously) on Day 1 (oxaliplatin at 130 mg/m 2 capecitabine 1000 Days...

10.1111/cas.16425 article EN cc-by-nc Cancer Science 2024-12-10

Introduction Aspirin is an effective antiplatelet drug for preventing cardiovascular events in high-risk subjects. However, patients with chronic kidney disease and undergoing hemodialysis (HD), its preventive efficacy remains controversial. The present study aimed to determine whether aspirin therapy reduces the risk of (CVD) all-cause mortality on HD. Methods We conducted a 5-y prospective cohort involving Major exposure variables included prescription (100 mg/d) no (nonaspirin). primary...

10.1111/hdi.12409 article EN Hemodialysis International 2016-03-01

This study investigated selenoprotein P expression, using immunohistochemistry, in gastric adenocarcinoma tissue microarrays constructed from 30 specimens and normal tissues (controls). Selenoprotein expression scores were significantly lower (17/30, 56.7%) than control (25/30, 83.3%). was more likely to be expressed well-to-moderately differentiated cases (13/17, 76.5%) with low differentiation (4/13, 30.8%) there no significant difference between tumour node metastasis (TNM) stage I – II...

10.1177/147323000903700120 article EN Journal of International Medical Research 2009-02-01

A simplified model not requiring a clinic visit is important for cardiovascular prevention. We compared such model, with one clinical measurements prediction of ischemic stroke.Five population-based Finnish cohorts comprising 14 296 men and 16 065 women aged 25-64 years were randomly recruited from 1982, followed up using the national registers until end 2007. The final Cox included age, prior history diabetes hypertension, happy marriage, capability to walk 500 m (self-estimate), regular...

10.1111/j.1747-4949.2011.00692.x article EN International Journal of Stroke 2011-11-02
Coming Soon ...